MicroRNA Involvement in the Regulation of Survivin in Peripheral Blood Mononuclear Cells from Rheumatoid Arthritis Patients
Overview
Authors
Affiliations
Aim: Impaired regulation of immune tolerance results in autoimmune diseases, such as rheumatoid arthritis (RA). Survivin is an anti-apoptotic protein and can induce cellular mitosis. In the current study, we assessed the transcript level of total survivin (survivin-TS) and its three major variants and evaluated the expression level of important micro RNAs (miRNAs) involved in survivin expression regulation in RA patients.
Method: Peripheral blood mononuclear cells (PBMCs) were isolated from 50 healthy controls and 50 RA-active patients. RNA extraction was performed and then single-strand complementary DNA was synthesized. Quantitative real-time polymerase chain reaction was used to assess the expression level of survivin-TS and its variants with effective miRNAs in PBMCs.
Results: Overexpression of survivin-2B (fold change = 1.57, P = 0.005), survivn-ΔEx3 (fold change = 1.93, P = 0.009) and downregulation of survivin-WT (fold change = 0.64, P = 0.0002) were found in PBMCs of patients, while messenger RNA (mRNA) expression of survivin-TS had no significant difference between RA patients and controls. Expression levels of miR-335-5p, miR-485-5p, miR-16-5p, miR-150-5p, miR-34a-5p, and miR-203a-3p were significantly increased in PBMCs from patients compared with healthy controls. In a correlation study, dysregulation of these miRNAs were not correlated with mRNA expression level of survivin.
Conclusion: While survivin-TS was not differently expressed in RA patients, its variants had altered expression. Although miRNAs were aberrantly expressed in PBMCs from RA subjects, they did not regulate survivin-TS. miRNAs might be involved in RA pathogenesis, but not through controlling survivin.
Ebrahimian H, Akhtari M, Akhlaghi M, Farhadi E, Jamshidi A, Alishiri G Immun Inflamm Dis. 2023; 11(7):e914.
PMID: 37506143 PMC: 10336681. DOI: 10.1002/iid3.914.
Multiple functions and regulatory network of miR-150 in B lymphocyte-related diseases.
Hu Y, Li Q, Wang P, Li X, Hu Z Front Oncol. 2023; 13:1140813.
PMID: 37182123 PMC: 10172652. DOI: 10.3389/fonc.2023.1140813.
Shomali N, Maashi M, Baradaran B, Daei Sorkhabi A, Sarkesh A, Mohammadi H Front Immunol. 2022; 13:839945.
PMID: 35309327 PMC: 8927965. DOI: 10.3389/fimmu.2022.839945.
Ren C, Li M, Zheng Y, Wu F, Du W, Quan R PeerJ. 2021; 9:e11427.
PMID: 34040897 PMC: 8127958. DOI: 10.7717/peerj.11427.
Imas J, Ruiz Zamarreno C, Zubiate P, Sanchez-Martin L, Campion J, Matias I Sensors (Basel). 2020; 20(21).
PMID: 33158306 PMC: 7663853. DOI: 10.3390/s20216289.